Longwood Fund
Longwood Fund creates and invests in science-based healthcare companies developing novel solutions for unmet medical needs.
About
Longwood Fund is a Boston-based venture capital firm specializing in the creation and investment of novel healthcare companies. The firm's mission is to identify groundbreaking scientific discoveries and transform them into viable companies that develop novel treatments for significant medical challenges. They actively co-found companies and collaborate closely with entrepreneurs and scientists to bring transformative therapies to market.
Key facts
At-a-glance profile data
- Website
- longwoodfund.com
- Type
- VC
- Headquarters
- Boston, United States
- Funds raised
- $650M
- Portfolio companies
- 34
- Stages
- SeedSeries ASeries BGrowth Equity
- Sector focus
- BiotechnologyHealthcarePharmaceuticalLife ScienceCell and Gene Therapy
Recent investments
“Investor Relations doesn't have it listed, but CEO RP speaking at Longwood (moderated by Chen Schor - board member) - 9/21/2022 at 9:50 AM EST - more information in comments.”
View on Reddit“Dr. Henry Ji to Participate in Longwood Healthcare Leaders Winter Webconference Panel on January 6th 2022.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
Frequently asked
What companies has Longwood Fund invested in?
Longwood Fund has invested in Khartis Therapeutics, Inc., Sidewinder Therapeutics, BridgeBio Pharma, Evommune, Inc., Avenzo Therapeutics and 29 more.